Charles N. Mills insider trades: Medline (MDLN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Charles reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | MDLN | ↑ Buy | 2,441,379 | $29.00 | $70.8M | Indirect | Dec 22, 2025 (4d) |
| Dec 18, 2025 | MDLN | ↑ Buy | 137,931 | $29.00 | $4.0M | By Spouse | Dec 22, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MDLN insiders
Open-market trades in the last 12 months
About Charles N. Mills's insider trades
Charles N. Mills is an insider at Medline (MDLN). Since Dec 18, 2025, Charles has reported 2 open-market purchases worth $74.8M and no sales on SEC Form 4. In the last 12 months: 2 buys ($74.8M).
Their filings also include grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDLN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.